롤링스톤
214610KOSDAQ49.5 / 100
Reference Date: 2026-09-08
Company InformationBased on 2025 Annual Report
Business Overview
Rolling Stone Co., Ltd., established in 2009, specializes in developing molecular diagnostic equipment and kits based on LabChip technology, holding patents in 17 countries. The company offers solutions for infectious disease diagnosis, A2 milk detection, immuno/biochemical diagnostic products, and is expanding into digital healthcare and fuel trading to diversify its portfolio and achieve sustainable growth.
Number of Employees
16people
Average Salary
54.3M KRW
Score Calculation Basis
Detailed Financial Score
In line with industry avg
Well below industry avg
Half of industry avg (excellent)
Avg ▲60.5% (2-year basis)
Avg ▲24.5% (2-year basis)
Avg ROE -104.4% (declining, 3yr)
Detailed News Sentiment
- Neutral트럼프 ‘풍성 금발’에 시선 집중…백악관 “조명 때문”
Trump's appearance with a fuller hairstyle fueled by AI-generated memes does not directly impact Rolling Stone's stock performance.
Detailed Momentum
Near 52w low (1%, downtrend)
1m 0% (flat)
Volume dry-up
Detailed Disclosure
- Neutral반기보고서 (2026.06)2026-08-14
- Neutral반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)2026-08-14
